The Association Between miRNA-223-3p Levels and Pain Severity in Fibromyalgia Syndrome: A Molecular Approach
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms27010176 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Zerrin Barut und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Medical Sciences, Faculty of Dentistry, Antalya Bilim University, 07910 Antalya, Türkiye. Hauptthemen laut MEDLINE: MicroRNAs, Fibromyalgia, Pain. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Fibromyalgia Syndrome (FMS) is a chronic syndrome commonly characterized by widespread musculoskeletal pain and fatigue. Current evidence suggests that FMS diagnosis relies on clinical evaluation and patient-reported symptoms. MicroRNAs, which serve as key regulators of gene expression, have been proposed to play a role in the pathogenesis of FMS and other chronic pain syndromes. In this pilot study, miRNA-223-3p expression levels were examined in patients with FMS, and their relationship with pain intensity—assessed using the Visual Analog Scale (VAS)was evaluated. To obtain a broader understanding of the inflammatory response, serum interleukin-1 beta (IL-1β) levels were also measured. miRNA-223-3p expression levels were significantly reduced in the FMS group compared with healthy controls (p < 0.05), whereas IL-1β levels did not differ significantly between the groups (p = 0.1135). The negative correlation between miRNA-223-3p and VAS scores indicates that lower miRNA levels are associated with increased pain severity. Overall, these results suggest that reduced miRNA-223-3p expression levels may be linked to neuroimmune processes and heightened pain perception in FMS. The findings provide valuable preliminary insights that may guide future studies with larger sample sizes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Basic Medical Sciences, Faculty of Dentistry, Antalya Bilim University, 07910 Antalya, Türkiye.
- Department of Internal Medicine, Division of Physical Medicine and Rehabilitation, Faculty of Medicine, Akdeniz University, 07070 Antalya, Türkiye.
- Department of Genetics and Bioengineering, Faculty of Engineering and Naturel Sciences, Istanbul Okan University, 34959 Istanbul, Türkiye.
- Department of Medical Biotechnology and Medical Biochemistry, Faculty of Medicine, Akdeniz University, 07070 Antalya, Türkiye.
- Institute of Health Sciences, Department of Molecular Medicine, Yeditepe University, 34755 Istanbul, Türkiye.
ORCID-Profile: Zerrin Barut, Özlem Karataş
Zitieren
APA
Barut, Z., Karataş, Ö., Akdeniz, F. T., Çırçırlı, B., Demir, S., & İsbir, T. (2025). The Association Between miRNA-223-3p Levels and Pain Severity in Fibromyalgia Syndrome: A Molecular Approach. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27010176
Vancouver
Barut Z, Karataş Ö, Akdeniz FT, Çırçırlı B, Demir S, İsbir T. The Association Between miRNA-223-3p Levels and Pain Severity in Fibromyalgia Syndrome: A Molecular Approach. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms27010176
BibTeX
@article{Barut2025,
author = {Barut, Zerrin and Karataş, Özlem and Akdeniz, Fatma Tuba and Çırçırlı, Bürke and Demir, Serpil and İsbir, Turgay},
title = {The Association Between miRNA-223-3p Levels and Pain Severity in Fibromyalgia Syndrome: A Molecular Approach},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms27010176}
}
EUVIMED